News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,757 Results
Type
Article (5004)
Company Profile (17)
Press Release (219736)
Section
Business (82210)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3675)
Job Trends (3902)
News (120111)
Policy (7498)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14760)
ALS (19)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (11)
Approvals (3690)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (424)
Cardiovascular disease (21)
Career advice (392)
Career pathing (2)
CAR-T (30)
Cell therapy (101)
Cervical cancer (2)
Clinical research (15998)
Collaboration (161)
Compensation (151)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (91)
Cystic fibrosis (16)
Data (490)
Depression (5)
Diabetes (38)
Diagnostics (2036)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40725)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37662)
Executive appointments (284)
FDA (3911)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (174)
Gene editing (15)
Generative AI (2)
Gene therapy (46)
GLP-1 (105)
Government (408)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (316)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7815)
IRA (3)
Job creations (1122)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2330)
Liver cancer (17)
Lung cancer (50)
Lymphoma (27)
Management (10)
Manufacturing (45)
MASH (27)
Medical device (3856)
Medtech (3857)
Mergers & acquisitions (7416)
Metabolic disorders (113)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (334)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (875)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (23)
Partnered (4)
Patents (21)
Patient recruitment (27)
Peanut (5)
People (24534)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4769)
Phase II (6945)
Phase III (5537)
Pipeline (526)
Policy (5)
Postmarket research (625)
Preclinical (1864)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (64)
Real estate (1873)
Recruiting (8)
Regulatory (5100)
Reports (14)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (671)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
United States (6704)
Vaccines (34)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (18)
Last 7 days (215)
Last 30 days (843)
Last 365 days (10215)
2025 (2555)
2024 (11029)
2023 (13193)
2022 (18660)
2021 (19679)
2020 (18239)
2019 (13209)
2018 (10205)
2017 (10001)
2016 (9157)
2015 (12121)
2014 (9587)
2013 (7708)
2012 (8331)
2011 (8797)
2010 (8635)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11431)
Australia (1602)
California (1830)
Canada (667)
China (67)
Colorado (78)
Connecticut (90)
Delaware (28)
Europe (24438)
Florida (258)
Georgia (32)
Idaho (23)
Illinois (110)
India (6)
Indiana (60)
Iowa (1)
Japan (64)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (39)
Maryland (214)
Massachusetts (1477)
Michigan (84)
Minnesota (135)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (537)
New Mexico (5)
New York (454)
North Carolina (316)
North Dakota (2)
Northern California (875)
Ohio (54)
Oklahoma (5)
Oregon (3)
Pennsylvania (332)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (671)
Tennessee (35)
Texas (215)
Utah (58)
Virginia (41)
Washington D.C. (8)
Washington State (161)
West Virginia (2)
Wisconsin (20)
224,757 Results for "haemonetics corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Haemonetics Announces Executive Leadership Updates
March 3, 2025
·
2 min read
Press Releases
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
February 24, 2025
·
1 min read
Deals
Haemonetics Corporation Completes Acquisition of Attune Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has completed its previously announced acquisition of privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device.
April 1, 2024
·
7 min read
Deals
Haemonetics Corporation Completes Acquisition of OpSens Inc.
Haemonetics Corporation has completed its previously announced acquisition of OpSens Inc.
December 12, 2023
·
8 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 6, 2025
·
1 min read
Press Releases
Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
February 7, 2025
·
2 min read
Genetown
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device
Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a limited market release of its new VASCADE MVP® XL mid-bore venous closure device.
June 18, 2024
·
4 min read
Press Releases
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
January 9, 2025
·
1 min read
Genetown
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
Haemonetics Corporation announced the pricing of its offering of $600,000,000 aggregate principal amount of 2.50% Convertible Senior Notes due 2029 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
May 23, 2024
·
11 min read
1 of 22,476
Next
